News & Events
LaVoie Health Science was recently included in the Boston Business Journals Fast 50 2021 which is a list of the fastest-growing private companies in Mass. Read the article HERE.
Donna L. LaVoie, President, CEO, and Founder of LaVoieHealthScience Interviewed by Global Business Reports
Donna LaVoie was recently interviewed by Global Business Reports. Read the interview HERE.
LaVoieHealthScience Builds on 2020 Momentum with an Updated Team Roster to Meet Client Growth in 2021
BOSTON & NEW YORK - January 7, 2021 (BUSINESS WIRE)--LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science...
LaVoieHealthScience Names James (Jim) Heins as Senior Vice President and Managing Director of its New York Practice
LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced the appointment of James (Jim) Heins as Senior Vice President and Managing Director of its New York practice, expanding the agency’s senior leadership team to seven members.
Our event calendar includes select industry, medical and investor conferences that LHS and clients will attend throughout the year.
The “2021 Preview: A 360 Degree Global Market View,” virtual webinar was designed to discuss global market trends on public and private United States, Europe, and China markets, JPM virtual week in January 2021, and more.
As we continue with virtual conferences in 2021, here are some tips to help you navigate the digital format and reach your target stakeholders at this year’s virtual conferences.
LaVoieHealthScience President and CEO, Donna LaVoie, contributed to the O’Dwyer’s PR News Magazine October issue focused on healthcare and medical public relations.
With ESG investing moving from tipping point to turning point, what impact will the new DOL rules have on investors and plan sponsors? Given the macro-level upheavals that have taken place so far in...